However, childhood cancer survivors have lower risk for registered COVID-19 infection relative to comparators. (HealthDay News) — Childhood cancer survivors have a lower risk for registered COVID-19 ...

22.7 percent of primary prevention aspirin users started aspirin without a physician's recommendation. (HealthDay News) — Almost 15 percent of U.S. adults aged 50 to 80 years are taking aspirin for ...

A trial tested the efficacy of corticosteroids in reducing interstitial fibrosis after kidney transplantation in low-risk patients.

The wearable, cuffless, over-the-counter (OTC) device utilizes photoplethysmography, an optical sensor technology to collect data from the user’s wrist. The data is then sent to the Hilo App where it ...

Introduction of immune checkpoint inhibitors linked to widening disparity for those with private insurance versus those without insurance.

The approval was supported by data from the randomized, double-blind, placebo-controlled, event-driven phase 3 FINEARTS-HF study.

Researchers evaluated an electronic health record-based intervention that identified patients with metastatic cancer for a multipronged approach to their in-hospital care. An EHR-based intervention ...

(HealthDay News) — The U.S. Food and Drug Administration has published more than 200 complete response letters, or decision letters, sent as replies to drug and biological product applications ...

SGLT2 inhibitors, compared with GLP-1 RAs, were associated with lower risks for osteoarthritis and joint replacement surgery among patients with T2D.

(HealthDay News) — Radiation therapy can promote the epidermal growth factor receptor (EGFR) ligand amphiregulin, which increases growth of existing metastases in patients with advanced solid tumors, ...

In recent study, 23 percent of NHANES primary prevention cohort currently using lipid-lowering therapies versus 47 percent eligible under U.S. guidelines.

Cannabidiol within the range consumers are taking with unregulated products linked to increase in liver enzymes.